Then, a company named Regeneron announced they would buy the company, and would “prioritize [consumer data's] privacy, ...

23andMe's co-founder and former chief executive, Anne Wojcicki, looks set to regain control of the business after emerging ...

Regeneron did not bid higher on the genetic testing company because of “its assessment of 23andMe’s remaining value,” ...

Anne Wojcicki's nonprofit will acquire substantially all of 23andMe's assets for $305 million, the company announced Friday.

Beleaguered genetic testing company 23andMe announced Friday that it has reached an agreement to sell itself to TTAM Research ...

Me is proposing to reopen its bankruptcy auction to entertain a final offer from a nonprofit operated by its co-founder, ...

Regeneron Pharmaceuticals has declined to submit a new bid for genetic testing company 23andMe exceeding its original winning ...

Added to that, 23andMe suffered a massive data breach in 2023 that resulted in information from about 7 million people being ...

In a statement, Regeneron said it would adhere to the existing privacy policy covering some 15 million customers, even as those consumers continue to have privacy concerns over sensitive genetic data.

The company’s co-founder and CEO ... Regeneron emphasized that it sees significant value in preserving and expanding 23andMe’s core mission of empowering individuals through genetic insights.